...
首页> 外文期刊>Frontiers in Microbiology >Comparative Analysis of Cellular Immune Responses in Treated Leishmania Patients and Hamsters against Recombinant Th1 Stimulatory Proteins of Leishmania donovani
【24h】

Comparative Analysis of Cellular Immune Responses in Treated Leishmania Patients and Hamsters against Recombinant Th1 Stimulatory Proteins of Leishmania donovani

机译:治疗的利什曼原虫患者和仓鼠对利什曼原虫 的重组Th1刺激蛋白的细胞免疫反应的比较分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Our prior studies demonstrated that cellular response of T helper 1 (Th1) type was generated by a soluble antigenic fraction (ranging from 89.9 to 97.1 kDa) of Leishmania donovani promastigote, in treated Leishmania patients as well as hamsters and showed significant prophylactic potential against experimental visceral leishmaniasis (VL). Eighteen Th1 stimulatory proteins were identified through proteomic analysis of this subfraction, out of which 15 were developed as recombinant proteins. In the present work, we have evaluated these 15 recombinant proteins simultaneously for their comparative cellular responses in treated Leishmania patients and hamsters. Six proteins viz. elongation factor-2, enolase, aldolase, triose phosphate isomerase, protein disulfide isomerase, and p45 emerged as most immunogenic as they produced a significant lymphoproliferative response, nitric oxide generation and Th1 cytokine response in PBMCs and lymphocytes of treated Leishmania patients and hamsters respectively. The results suggested that these proteins may be exploited for developing a successful poly-protein and/or poly-epitope vaccine against VL.
机译:我们的先前研究表明,在治疗的利什曼原虫患者以及仓鼠中,利什曼原虫donovani前鞭毛体的可溶性抗原级分(范围从89.9到97.1 kDa)产生了T辅助1(Th1)型细胞应答,并显示出对实验性的显着预防潜力内脏利什曼病(VL)。通过蛋白质组学分析,鉴定了18个Th1刺激蛋白,其中15个被开发​​为重组蛋白。在目前的工作中,我们同时评估了这15种重组蛋白在治疗利什曼原虫患者和仓鼠中的比较细胞反应。六种蛋白质,即。延伸因子2,烯醇酶,醛缩酶,磷酸三糖异构酶,蛋白质二硫键异构酶和p45的免疫原性最高,因为它们分别在治疗的利什曼原虫患者和仓鼠的PBMC和淋巴细胞中产生明显的淋巴增生反应,一氧化氮生成和Th1细胞因子反应。结果表明,这些蛋白可用于开发成功的针对VL的多蛋白和/或多表位疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号